C
Cellectis SA D
D
CLLS
1.59100
USD
-0.02
(-1.18%)
مغلق
حجم التداول
305
الربح لكل سهم
-1
العائد الربحي
-
P/E
-4
حجم السوق
159,561,514
الأخبار المقالات
العنوان: Cellectis SA
القطاع: Healthcare
الصناعة: Biotechnology
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.